Focus: Hyperfine is a biotechnology company specializing in portable MRI scanner technology, headquartered in Guilford, CT. The company focuses on enabling MRI imaging in neurology and oncology applications with mobile, accessible alternatives to traditional fixed systems.
Profile data last refreshed 4h ago · AI intelligence enriched 2w ago
Stable — net +3 jobs in 30d
4 added, 1 removed. Backfill posture.
Hyperfine is a high-risk, high-reward early-stage medtech play best suited for professionals seeking deep technical ownership in hardware/imaging innovation over near-term stability.
Automated analysis based on publicly available data (FDA, SEC, ClinicalTrials.gov). May be incomplete or delayed. This score does not reflect insider knowledge and should not be used as the sole basis for investment or employment decisions.
Help build intelligence for Hyperfine
No one has shared interview or compensation data for this company yet. You'll earn 7 days of Pro access.
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.
Generated by Claude from Hyperfine's SEC filings, pipeline programs, hiring velocity, FDA actions, and WARN data. Inference, not editorial — verify before quoting.
AIIMS Delhi Introduces Hyperfine Swoop System, India’s First Portable MRI for Bedside Brain Imaging - Digital Health News
AIIMS Delhi Introduces Hyperfine Swoop System, India’s First Portable MRI for Bedside Brain Imaging Digital Health News
DRADS Capital - 2026 Investor Profile, Portfolio, Team & Investment Trends - Tracxn
DRADS Capital - 2026 Investor Profile, Portfolio, Team & Investment Trends Tracxn
Based on last 4 crawl cycles
Source: USCIS H-1B Employer Data Hub
Upgrade to Pro to access AI interview prep brief and other premium pharma intelligence.
Upgrade to Pro — $25/mo